MwanzoALK-B • CPH
add
ALK-Abello A/S
Bei iliyotangulia
kr 167.50
Bei za siku
kr 163.70 - kr 167.10
Bei za mwaka
kr 74.30 - kr 185.60
Thamani ya kampuni katika soko
33.93B DKK
Wastani wa hisa zilizouzwa
elfu 139.20
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
CPH
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (DKK) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.37B | 21.06% |
Matumizi ya uendeshaji wa biashara | 603.00M | -1.15% |
Mapato halisi | 201.00M | 204.55% |
Kiwango cha faida halisi | 14.63 | 151.81% |
Mapato kwa kila hisa | — | — |
EBITDA | 331.00M | 110.83% |
Asilimia ya kodi ya mapato | 25.28% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (DKK) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 420.00M | 154.55% |
Jumla ya mali | 7.04B | 9.11% |
Jumla ya dhima | 2.13B | -6.47% |
Jumla ya hisa | 4.92B | — |
hisa zilizosalia | 221.19M | — |
Uwiano wa bei na thamani | 7.53 | — |
Faida inayotokana na mali | 9.54% | — |
Faida inayotokana mtaji | 12.41% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (DKK) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 201.00M | 204.55% |
Pesa kutokana na shughuli | 259.00M | 2,777.78% |
Pesa kutokana na uwekezaji | -98.00M | 18.33% |
Pesa kutokana na ufadhili | -33.00M | -138.82% |
Mabadiliko halisi ya pesa taslimu | 129.00M | 596.15% |
Mtiririko huru wa pesa | 96.00M | 165.14% |
Kuhusu
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1923
Tovuti
Wafanyakazi
2,806
